FindTrial
Sign In

How CRP/Albumin and Albumin/Globulin Ratios Help Predict Bad Outcomes in Heart Failure Patients.

Predicting Adverse Outcomes in Heart Failure Cases: The Utility of CRP/Albumin and Albumin/Globulin Ratios. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/087121
Enrollment
75
Registered
2025-05-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I502- Systolic (congestive) heart failure

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Datta Meghe Institute of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Indian inhabitant Heart failure cases, diagnosed according to Symptoms, Echocardiography, and HF Biomarkers.

Exclusion criteria

Exclusion criteria: 1. Chronic Hepatic diseases 2. Renal transplant 3. Malignancy 4. Acute coronary syndrome 5. No echocardiographic structural or functional abnormalities Autoimmune disease

Design outcomes

Primary

MeasureTime frame
It will be associated with worse outcomes for heart failure patients. Conversely, the A/G ratio can draw attention to inflammation, infection, cachexia and nutritional health, possibly pointing to the advancement of the disease.Timepoint: Assessments will be done at 6 months.—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Ashish Prakash Anjankar

Datta Meghe Institute of Higher Education and Research

ashish.anjankar@gmail.com9423108367

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026